Detalhe da pesquisa
1.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35139274
2.
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Oncologist
; 28(10): 845-855, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37318349
3.
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 20(11): 1587-1601, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31575503
4.
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
Breast Cancer Res Treat
; 171(1): 111-120, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29744674
5.
The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.
Qual Life Res
; 26(10): 2763-2772, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28664460
6.
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.
JCO Glob Oncol
; 10: e2300285, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38206277
7.
Transfusion transmissible infections among blood donors in Ghana: A 3-year multicentered health facility-based retrospective study.
Health Sci Rep
; 6(11): e1681, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37927541
8.
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.
Clin Cancer Res
; 28(4): 629-636, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34887261
9.
Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(4): e214103, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33877311
10.
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.
NPJ Breast Cancer
; 7(1): 29, 2021 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33753748
11.
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 27(12): 3329-3338, 2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33820779
12.
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
J Clin Oncol
; 39(35): 3938-3958, 2021 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34324366
13.
Antiemetics: ASCO Guideline Update.
J Clin Oncol
; 38(24): 2782-2797, 2020 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32658626
14.
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
J Clin Oncol
; 35(28): 3240-3261, 2017 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28759346
15.
Antiemetics: American Society of Clinical Oncology Focused Guideline Update.
J Clin Oncol
; 34(4): 381-6, 2016 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26527784
16.
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Clin Breast Cancer
; 16(6): 471-479.e1, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27569274
17.
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
J Clin Oncol
; 32(34): 3840-7, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25349301
18.
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol
; 32(29): 3307-29, 2014 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-25185096
19.
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
BMC Res Notes
; 6: 507, 2013 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-24304724
20.
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.
Clin Cancer Res
; 19(19): 5505-12, 2013 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23965901